Vanda Pharmaceuticals Inc logo

Vanda Pharmaceuticals Inc

$ 9.53 -0.14 (-1.45%) 10:08 PM EST
On watch
P/E:
47.65
P/B:
1.08
Market Cap:
$ 539.03M
Enterprise V:
$ 117.62M
Volume:
307.95K
Avg Vol (2M):
394.95K
Also Trade In:
Volume:
307.95K
Market Cap $:
539.03M
PE Ratio:
47.65
Avg Vol (2-Month):
394.95K
Enterprise Value $:
117.62M
PB Ratio:
1.08
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.
Name Current Vs Industry Vs History
Cash-To-Debt 38.23
Equity-to-Asset 0.84
Debt-to-Equity 0.02
Debt-to-EBITDA 0.64
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.2
Distress
Grey
Safe
Beneish M-Score -3.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 20.48
9-Day RSI 29.58
14-Day RSI 35.19
6-1 Month Momentum % -10.56
12-1 Month Momentum % -40.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.62
Quick Ratio 5.6
Cash Ratio 4.99
Days Inventory 17.01
Days Sales Outstanding 47.34
Days Payable 103.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.1

Financials (Next Earnings Date:2022-11-03 Est.)

VNDA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VNDA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 262.696
EPS (TTM) ($) 0.2
Beta 0.61
Volatility % 29.97
14-Day RSI 35.19
14-Day ATR ($) 0.334119
20-Day SMA ($) 10.146
12-1 Month Momentum % -40.61
52-Week Range ($) 9.24 - 21.4399
Shares Outstanding (Mil) 56.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vanda Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Vanda Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.